$VICR

Davies Philip D sold $129K of VICR

Davies Philip D (VP Global Sales & Marketing) sold 400 shares of VICOR CORP (VICR) at $323.44 ($0.13M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Davies Philip D
Published Jun 2, 2026, 2:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 2:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
high confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Because it’s a planned sale and not tied to operational updates, the market impact is typically limited to short-term sentiment rather than fundamentals.

02

Market read

Traders may note the disclosure for positioning/sentiment, but it does not introduce new catalysts.

03

What to watch

The filing does not disclose intent beyond the plan; without additional context (e.g., total insider activity trend), it’s hard to infer directional conviction.

Relevance 6/10Novelty 2/10Timing: Filed June 2, 2026; sale executed June 1, 2026.

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by a VP Global Sales & Marketing, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

ViCOR Corp disclosed an officer/director open-market sale: 400 shares sold at $323.4450 under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief unless accompanied by other news.

Evidence & confidence

The filing is a routine Form 4 sale executed under a pre-arranged 10b5-1 plan, with no earnings, guidance, or deal changes reported.

Market effects

No sector-level read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification or tax planning; the 10b5-1 structure reduces the informational content versus discretionary selling.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • Davies Philip D

    VP Global Sales & Marketing; sold 400 shares under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: